The Online Investor
Meridian Bioscience Inc. (VIVO)

Meridian Bioscience is a life science company with principal businesses in the development, manufacture, sale and distribution of diagnostic testing systems and kits and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, Polymerase Chain Reaction (PCR) master mixes and bioresearch reagents. Co.'s reportable segments are: Diagnostics, which includes diagnostic tests and transport media; and Life Science, which develops, manufactures, sells and distributes bulk antigens, antibodies, immunoassay blocking reagents, PCR master mixes, isothermal reagents, enzymes, nucleotides and bioresearch reagents.
Company Name: 
Meridian Bioscience Inc.
Website: 
www.meridianbioscience.com
Sector: 
Medical Instruments & Supplies
Quotes delayed 20 minutes

Email EnvelopeFree VIVO Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
VIVO Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Meridian Bioscience Inc. (VIVO) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.